Increase by naloxone of arginine vasopressin and oxytocin responses to insulin-induced hypoglycemia in obese men

No abstract is available for this paper.

• Publication year

  1990

• Venue

  Journal of Endocrinological Investigation

• Publication date

  1990-10-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/BF03349617PMID 2292659
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Inhibitory effect of ethanol on the arginine vasopressin response to insulin-induced hypoglycemia and the role of endogenous opioids.

  1990cited by this paper
• Arginine vasopressin and oxytocin responses to insulin-induced hypoglycemia in type 1 (insulin-dependent) diabetes.

  1989cited by this paper
• Naloxone abolishes the inhibiting effect of somatostatin on the release of oxytocin evoked by insulin-induced hypoglycemia in humans.

  1989cited by this paper
• Effects of oxytocin delivery on counter-regulatory hormone response in insulin-dependent (type 1) diabetic subjects.

  1989cited by this paper
• Neuroendocrine control of blood tonicity and volume.

  1989cited by this paper
• 1 Neuroendocrine control of blood tonicity and volume

  1989cited by this paper
• Naloxone inhibition of postprandial growth hormone releasing hormone-induced growth hormone release in obesity.

  1989cited by this paper
• Opioid-mediated inhibition of oxytocin during insulin-induced hypoglycemic stimulation of vasopressin in man.

  1988cited by this paper
• Opioid peptides and metabolic regulation

  1988cited by this paper
• Plasma B-endorphin resistance to dexamethasone suppression in obese patients

  1988cited by this paper
• Impaired beta-endorphin response to human corticotropin-releasing hormone in obese children.

  1988cited by this paper
• Oxytocin response to insulin-induced hypoglycemia in obese subjects before and after weight loss

  1988cited by this paper
• Pharmacological doses of oxytocin affect plasma hormone levels modulating glucose homeostasis in normal man.

  1988cited by this paper
• Naloxone decreases the inhibiting effect of ethanol on the release of arginine-vasopressin induced by cigarette smoking in man.

  1987cited by this paper
• Changes in oxytocin and vasopressin secretion during sexual activity in men.

  1987cited by this paper
• Dexamethasone fails to suppress hyperendorphinaemia of obese children.

  1987cited by this paper
• The effect of enkephalin analogue on pituitary hormone release in human obesity.

  1987cited by this paper
• Hormonal Control of Haemostasis During Hypoglycaemia in Diabetes Mellitus

  1987cited by this paper
• Naloxone increases the response of growth hormone and prolactin to stimuli in obese humans

  1987cited by this paper
• PLASMA OXYTOCIN, ARGININE VASOPRESSIN AND ATRIAL NATRIURETIC PEPTIDE RESPONSES TO INSULIN‐INDUCED HYPOGLYCAEMIA IN MAN

  1987cited by this paper
• Plasma beta-endorphin in response to oral glucose tolerance test in obese patients.

  1987cited by this paper
• EFFECT OF OBESITY AND WEIGHT LOSS ON THE ARGININE VASOPRESSIN RESPONSE TO INSULIN‐INDUCED HYPOGLYCAEMIA

  1987cited by this paper
• Hyperendorphinemia in obesity and relationships to affective state.

  1986cited by this paper
• Hyperendorphinemia in obese children and adolescents.

  1986cited by this paper
• Naloxone effects on plasma vasopressin and oxytocin concentrations elevated by histamine, nicotine, isoproterenol and an acute increase in [NaCl] in cerebrospinal fluid.

  1986cited by this paper
• RESPONSES OF NEUROHYPOPHYSIAL PEPTIDES TO HYPERTONIC SALINE AND INSULIN‐INDUCED HYPOGLYCAEMIA IN MAN

  1986cited by this paper
• Alpha 1-adrenergic receptor activation releases vasopressin and oxytocin from perfused rat hypothalamic explants.

  1986cited by this paper
• EVIDENCE FOR THE PARTICIPATION OF ENDOGENOUS OPIOIDS IN THE SYMPATHOADRENAL RESPONSE TO HYPOGLYCAEMIA IN MAN

  1985cited by this paper
• Peptides and feeding.

  1985cited by this paper
• Sugar, opioids and binge eating.

  1985cited by this paper
• Endogenous opioid peptides and hypothalamic neuroendocrine neurones.

  1985cited by this paper
• THE EFFECT OF VASOPRESSIN INFUSION ON GLUCOSE METABOLISM IN MAN

  1985cited by this paper
• The Regulation of the Function of the Posterior Pituitary with Special Reference to the Role of Opioid Peptides1

  1985cited by this paper
• Elevated plasma levels of β-endorphin in a group of women with polycystic ovarian disease *

  1984cited by this paper
• Opioids, feeding, and anorexias.

  1984cited by this paper
• Elevated plasma levels of beta-endorphin in a group of women with polycystic ovarian disease.

  1984cited by this paper
• Simultaneous radioimmunoassay for plasma arginine-vasopressin and oxytocin using DEAE Sephadex A 25 extraction

  1984cited by this paper
• Glucose responding neurons in the nucleus tractus solitarius of the rat: in vitro study.

  1984cited by this paper
• Opioids, feeding, and anorexias.

  1984cited by this paper
• Posterior pituitary function in health and disease.

  1983cited by this paper
• Central nervous system mediators of vasopressin release.

  1983cited by this paper
• Neuroendocrine effects of endogenous opioid peptides in human subjects: a review.

  1983cited by this paper
• Origin of insulin-receptive nerve terminals in rat median eminence.

  1983cited by this paper
• Extreme sensitivity of diabetic mice to naloxone-induced suppression of food intake.

  1982cited by this paper
• The role of the endogenous opiates as regulators of appetite.

  1982cited by this paper
• Altered hypothalamic and sympathetic responses to hypoglycaemia in familial obesity.

  1982cited by this paper
• Endogenous opiates and energy balance.

  1982cited by this paper
• Glucoreceptors controlling feeding and blood glucose: location in the hindbrain.

  1981cited by this paper
• Arginine vasopressin response to insulin-induced hypoglycemia in man.

  1981cited by this paper
• Insulin binding sites localized to nerve terminals in rat median eminence and arcuate nucleus.

  1980cited by this paper
• The neuroendocrine control of appetite: the role of the endogenous opiates, cholecystokinin, TRH, gamma-amino-butyric-acid and the diazepam receptor.

  1980cited by this paper
• Insulin-binding sites in the rat brain: in vivo localization to the circumventricular organs by quantitative radioautography.

  1979cited by this paper
• Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance. National Diabetes Data Group.

  1979cited by this paper
• beta-Endorphin is associated with overeating in genetically obese mice (ob/ob) and rats (fa/fa).

  1978cited by this paper
• The role of central adrenergic receptors in the reflex release of oxytocin.

  1978cited by this paper
• Plasma-arginine-vasopressin response to insulin-induced hypoglycaemia.

  1977cited by this paper
• Relationship between plasma and cerebrospinal fluid insulin levels of dogs.

  1977cited by this paper

• Molecular Interaction Between Vasopressin and Insulin in Regulation of Metabolism: Impact on Cardiovascular and Metabolic Diseases

  2024cites this paper
• Opioids and reproduction.

  2019cites this paper
• Metabolic Effects of Oxytocin.

  2019cites this paper
• Effect of intrapleural oxytocin injection on blood glucose level in rat (rattus norvegicous).

  2014cites this paper
• Oxytocin increases glucose uptake in neonatal rat cardiomyocytes.

  2010cites this paper
• The oxytocin receptor system: structure, function, and regulation.

  2001cites this paper
• Oxytocin in the human--regulation of derivations and destinations.

  1997cites this paper
• Different effects of the serotonergic agonists buspirone and sumatriptan on the posterior pituitary hormonal responses to hypoglycemia in humans.

  1996cites this paper
• Elevated basal adrenocorticotropin and evidence for increased central opioid tone in highly trained male athletes.

  1995cites this paper
• The effects of glucose ingestion and fasting on plasma immunoreactive beta-endorphin, adrenocorticotropic hormone and Cortisol in obese subjects

  1991cites this paper